Linear scleroderma

L12_LINEARSCLERODERMA

scleroderma: Scleroderma is a rare autoimmune connective tissue disorder characterized by abnormal hardening of the skin and, sometimes, other organs. It is classified into two main forms: localized scleroderma and systemic sclerosis (SSc), the latter comprising three subsets; diffuse cutaneous SSc (dcSSc), limited cutaneous SSc (lcSSc) and limited SSc (lSSc) (see these terms).

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 L94.1
Cause of death: ICD-10 L94.1

2 out of 7 registries used, show all original rules.

28

diagram downward connector

Check minimum number of events None

28

diagram downward connector

Include endpoints None

28

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

28

diagram downward connector
L12_LINEARSCLERODERMA

Control definitions

Control exclude L12_OTHERSKINSUBCUTIS

Extra metadata

Level in the ICD hierarchy 4
First used in FinnGen datafreeze DF2
Parent code in ICD-10 L94
Name in latin Scleroderma lineare

Summary Statistics

Key figures

All Female Male
Number of individuals 28 21 7
Unadjusted prevalence (%) 0.01 0.01 0.00
Mean age at first event (years) 41.05 39.89 44.52

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: L12_LINEARSCLERODERMA – Linear scleroderma
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Linear scleroderma

Endpoint not on priority list, no data to show.